COMMUNIQUÉS West-GlobeNewswire

Anti-Snoring Mouthpiece vs Nose Strips: Consumer Analysis Explains Why Product Format May Matter More Than Brand
10/01/2026
How Jaw-Positioning Devices and Nasal Products Differ — SleepZee Examined Within Mouthpiece Category Context Chicago, IL, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and [...]
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
10/01/2026
Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13 th , 2026 Phase 1 dose-escalation [...]
Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)
10/01/2026
Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access expands through telehealth — here is what the RenuviaRX platform model, pricing structure, and [...]
MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs
10/01/2026
Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading Into 2026 NEWARK, DE, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This [...]
GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained
10/01/2026
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement — What The Science Shows And What It Doesn't MIAMI, FL, Jan. 09, 2026 (GLOBE NEWSWIRE) -- [...]
Alumis Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
09/01/2026
SOUTH SAN FRANCISCO, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated [...]
La Croix-Rouge canadienne sollicite des dons afin de bonifier le soutien offert aux personnes touchées par la crise dans la Nation crie de Pimicikamak
09/01/2026
WINNIPEG, 09 janv. 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne a mis sur pied le Fonds de secours : Crise de 2026 dans la Nation crie de Pimicikamak pour venir en aide aux personnes touchées par la panne de [...]
Canadian Red Cross opens appeal to expand support for the Pimicikamak Cree Nation Crisis
09/01/2026
WINNIPEG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the 2026 Pimicikamak Cree Nation Crisis Appeal to provide support for those impacted by the power outage in Pimicikamak Cree Nation, [...]
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/01/2026
CAMBRIDGE, Mass., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with [...]
U.S. Neurology Associates Partners with M33 Growth to Transform Neurological Care
09/01/2026
DALLAS and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- M33 Growth, a Boston-based venture and growth-stage investment firm, today announced its partnership with U.S. Neurology Associates (“USNA” or the “Company”), a [...]
Cooper Aerobics Partners with The Stayton at Museum Way
09/01/2026
Wellness Center Management & Wellness Programming by Cooper DALLAS and FORT WORTH, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cooper Wellness Strategies (CWS), a Cooper Aerobics company, expands its partnership with [...]
Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
10/01/2026
- Rapidly transforming into a leading global biopharma company COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including [...]
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/01/2026
BRISBANE, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on January 5, 2026, the Compensation Committee of the Board of Directors of Vera Therapeutics granted [...]
Most Popular SARMS for Bulking, Muscle Building and Strength 2026: Latest SARM Stacks for Muscle Growth & Bodybuilding - CrazyBulk
09/01/2026
Best SARM for muscle growth and strength for 2026 from leading supplement company CrazyBulk - which SARMS stack is best for bulking cycles and faster recovery" New York City,, Jan. 09, 2026 (GLOBE NEWSWIRE) -- "SARMs [...]
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
09/01/2026
TAIZHOU, China, Jan. 09, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the “Company”), today announced that it has entered into a definitive agreement with a single investor for the purchase [...]
Gastro Center of Maryland Expands Columbia Team with New Board-Certified Gastroenterologists
09/01/2026
COLUMBIA, Md., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Gastro Center of Maryland is pleased to announce the addition of new board-certified gastroenterologists to its Columbia location at 7120 Minstrel Way, Suite 100. This [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/01/2026
BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
09/01/2026
New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US Purpose-built facility will strengthen Novartis RLT manufacturing network [...]
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
09/01/2026
New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US Purpose-built facility will strengthen Novartis RLT manufacturing network [...]

Pages